Literature DB >> 33411729

Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.

Sona Frankova1, Mariia Lunova2, Halima Gottfriedova1, Renata Senkerikova1,3, Magdalena Neroldova2, Jozef Kovac4, Eva Kieslichova5, Vera Lanska6, Petr Urbanek3,7, Julius Spicak1, Milan Jirsa2,3, Jan Sperl1,3.   

Abstract

Liver stiffness is a reliable non-invasive predictor of Hepatic Venous Pressure Gradient (HVPG) above 10 mm Hg. However, it failed to predict higher thresholds of HVPG. Our aim was to investigate whether liver stiffness and selected previously published non-invasive blood biomarkers could predict higher HVPG thresholds in liver transplant candidates without ongoing alcohol use. One hundred and nine liver transplant candidates with liver cirrhosis of various aetiologies underwent direct HVPG measurement, liver stiffness measurement by 2D shear-wave elastography (Aixplorer Multiwave, Supersonic Imagine, France) and assessment of blood HVPG biomarkers (osteopontin, VCAM-1, IL-6, TNF-α, IL-1ra/IL-1F3 and ELF score). The correlation between liver stiffness and HVPG was linear up to 30 mm Hg of HVPG (r = 0.765, p < 0.0001). The regression lines had similar slopes for HVPG values below and above 16 mm Hg (p > 0.05) and the correlation in patients with HVPG <16 mm Hg (r = 0.456, p = 0.01) was similar to patients with HVPG ≥ 16 mm Hg (r = 0.499, p < 0.0001). The correlation was similar in the subgroup patients with alcoholic (r = 0.718, p < 0.0001), NASH (r = 0.740, p = 0.008), cryptogenic (r = 0.648, p = 0,0377), cholestatic and autoimmune (r = 0.706, p < 0.0001) and viral cirrhosis (r = 0.756, p < 0.0001). Liver stiffness distinguished patients with HVPG above 16, and 20 mm Hg with AUROCs 0.90243, and 0.86824, sensitivity 0.7656, and 0.7027, and specificity 0.9333, and 0.8750. All studied blood biomarkers correlated better with liver stiffness than with HVPG and their AUROCs did not exceed 0.8 at both HVPG thresholds. Therefore, a composite predictor superior to liver stiffness could not be established. We conclude that liver stiffness is a clinically reliable predictor of higher HVPG thresholds in non-drinking subjects with advanced liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33411729      PMCID: PMC7790429          DOI: 10.1371/journal.pone.0244934

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  56 in total

1.  Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

Authors:  Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Hong Gao; Robert Makuch
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

2.  MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; James Babb; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-09

3.  Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.

Authors:  D Lebrec; P De Fleury; B Rueff; H Nahum; J P Benhamou
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

4.  Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

Authors:  J Parkes; I N Guha; P Roderick; S Harris; R Cross; M M Manos; W Irving; A Zaitoun; M Wheatley; S Ryder; W Rosenberg
Journal:  J Viral Hepat       Date:  2011-01       Impact factor: 3.728

5.  The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Authors:  E E Powell; W G Cooksley; R Hanson; J Searle; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

6.  Portal pressure, presence of gastroesophageal varices and variceal bleeding.

Authors:  G Garcia-Tsao; R J Groszmann; R L Fisher; H O Conn; C E Atterbury; M Glickman
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

7.  Enhanced liver fibrosis (ELF) score: Reference ranges, biological variation in healthy subjects, and analytical considerations.

Authors:  Antonín Jabor; Zdenek Kubíček; Soňa Fraňková; Renáta Šenkeříková; Janka Franeková
Journal:  Clin Chim Acta       Date:  2018-05-14       Impact factor: 3.786

8.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

9.  Variability of Liver Shear Wave Measurements Using a New Ultrasound Elastographic Technique.

Authors:  David P Nadebaum; Amanda J Nicoll; Siddharth Sood; Alexandra Gorelik; Robert N Gibson
Journal:  J Ultrasound Med       Date:  2017-09-29       Impact factor: 2.153

10.  Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

Authors:  Moritz Kleine; Marc Riemer; Till Krech; Daphne DeTemple; Mark D Jäger; Frank Lehner; Michael P Manns; Jürgen Klempnauer; Jürgen Borlak; Hueseyin Bektas; Florian W R Vondran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more
  1 in total

1.  Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.

Authors:  M Lunova; S Frankova; H Gottfriedova; R Senkerikova; M Neroldova; J Kovac; E Kieslichova; V Lanska; E Sticova; J Spicak; M Jirsa; J Sperl
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.